Curiteva, a privately held technology and manufacturing company based in Huntsville, AL announces the commercial launch of its Inspire Porous PEEK HAFUSE Cervical Interbody System.

Huntsville, AL based technology company Curiteva is pleased to announce the expansion of its patent portfolio with the issuance of the third Utility Patent in support of their novel Inspire 3D printed porous PEEK with HAFUSE technology. This marks the 16th issued patent for Curiteva strengthening their position as a market leader in the 3D printing of porous PEEK.

Curiteva announced a limited commercial release utilizing its recently FDA-cleared Inspire Porous PEEK HAFUSE Cervical Interbody System. Curiteva pioneered and received clearance of the world’s first 3D printed, fully interconnected porous PEEK structure, utilizing internally developed Fused Filament Fabrication.

BONEZONE reports that Curiteva received FDA 510(k) clearance for Inspire Porous PEEK. The cervical interbody system is manufactured through a proprietary and patented Fused Filament Fabrication (FFF) 3D printer that is designed, programmed and built by Todd Reith.

Orthopedics This Week reports on the U.S. Food and Drug Administration (FDA) granting 510(k) clearance to a truly novel 3D printed PEEK implant.

Curiteva announces the first FDA 510(k) cleared 3D printed PEEK implant, the Inspire Porous PEEK Cervical Interbody System with HA^FUSE Technology.

Curiteva, Inc announced record revenue for Q3 2020 with the successful launch of their Prodigy Open and MIS posterior fixation systems.

Curiteva, Inc. announced today the addition of Steve Cichy as a Strategic Advisor to the rapidly growing technology company.

Curiteva announced a market-shifting transaction with the acquisition of FossiLabs, a company focused on the development of Fused Filament Fabrication 3D printed PEEK medical implants.